CIK 0001953926 · <br>Emerging growth company
Zenas BioPharma, Inc.
Sign in to watch- Ticker
- ZBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-271-2954
- Business address
- 852 WINTER STREET, SUITE 250, WALTHAM, MA, 02451
- Former names
- Zenas BioPharma (Cayman) Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-12 | Oliveira Orlando Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +410,000 | 410,000 | ||
| 2024-09-12 | Farmer Joseph L See Remarks | Grant or award · Stock Option (Right to Buy) | +206,000 | 206,000 | ||
| 2024-09-12 | Fox Jennifer A. See Remarks | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2024-09-12 | MOULDER LEON O JR Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,486,000 | 1,486,000 | ||
| 2024-09-12 | Nunn Jason Raleigh Director | Grant or award · Stock Option (Right to Buy) | +37,000 | 37,000 |
Page 8 of 8 · 145 trades